An observational study in Fetal Macrosomia, sponsored by Aljazeera Hospital. Status unknown at 1 site in Egypt. Open to female participants aged 18 Years to 43 Years. Per ClinicalTrials.gov, last updated 2019-01-09.
Sponsored by Aljazeera Hospital · Observational
Fetal macrosomia defined as birth weight above 90th centile ,macrosomia occurs in 42-62%of pregnancy complicated by type 1 diabetes mellitus ,in 30-56% of pregnancy complicated by type 2 diabetes mellitus .
-The delivery of macrosomic infant has potentially severe consequence for both the newborn and mother .Increased birth weight increase the risk in the fetus of shoulder dystocia and premature brachial plexus injury ,and those infant weighing above 4500g are at increased risk for neonatal morbidity ,including the need for assisted ventilation and meconium aspiration .Maternal complication result from operative delivery and include postpartum hemorrhage ,third or fourth degree laceration and postpartum infection .
Estimated fetal body weight is needed especially when head measurement is impossible whenever the fetal head is positioned low in pelvic brim .A convenient method for estimating fetal body weight without head measurement was thus required .
-The human placenta develop with the principal function of providing nutrients and oxygen to the fetus ,adequate fetal growth and subsequent normal birth weight depend on normal placenta .
32 studies on the registry are indexed under Fetal Macrosomia; 6 are open to participants now.
This study's planned enrollment of 102 is below the median of 239 across 17 observational studies indexed under Fetal Macrosomia.
Browse Fetal Macrosomia studies →Aljazeera Hospital is the lead sponsor of 64 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Singleton gestational Gestational age over 16-20 weeks with Intact membrane with Normal umbilical morphology (two arteries and one vein ) with DM in one group and no medical disorders in another group
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Pregnant women with diabetes mellitus will be examined by us to measures placental volume and thickness ,IV thickness and HbA1c
Diagnostic Test: Ultrasound · Diagnostic Test: HbA1c level in blood
Pregnant women with no medical disorders will be examined by us to measures placental volume and thickness ,IV thickness and HbA1c
Diagnostic Test: Ultrasound · Diagnostic Test: HbA1c level in blood
Ultrasound will be done to every pregnant lady
a blood sample will be taken to measure HbA1c level
the number of paticipants who will have babies with macrosomias
To detect number of fetuses who will develop macrosomia
Time frame: within a week from delivery
Plan to share: No — the data that willbe obtained from this research will be published
No publications or documents are linked to this record.
Started Mar 2018 (actual). Primary completion is estimated for May 2019, 14 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aljazeera Hospital